Abstract
One-third of humanity harbors a lifelong infection with Toxoplasma gondii. This parasite undergoes sexual reproduction in cats and asexual reproduction in any warm-blooded intermediate hosts. The cycle progresses as cats ingest these hosts, containing the parasite’s tissue cysts. Such infections can alter behaviors in both animals and humans, potentially increasing predation risk by felines—usually seen as parasite-induced manipulations. This study aims to delineate toxoplasmosis’s effects on cognitive abilities and compare these to the effects of human cytomegalovirus (CMV), which also infects the brain but is not spread through predation. We evaluated the cognitive performance of 557 students, who had been examined for Toxoplasma and CMV infections, using intelligence, memory, and psychomotor tests. Results indicated cognitive impairments in seropositive individuals for both pathogens, with variations in cognitive impact related to sex and Rh factor. Specifically, Toxoplasma was associated with lower IQ in men, whereas CMV predominantly with worse women’s memory and reaction speeds. Analysis of antibody concentrations hinted that certain Toxoplasma-associated cognitive detriments may wane (impaired intelligence) or worsen (impaired reaction times) over time following infection. The findings imply that cognitive impairments from both neurotropic pathogens are likely due to pathological changes in the brain rather than direct manipulative actions by the parasites.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Czech Science Foundation supported the work (Grants No. P303/16/20958 and 22-20785S).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study received approval from the IRB of the Faculty of Science Charles University (protocol numbers 2009/06 and 2013/07).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The complete dataset is available at Figshare: https://doi.org/10.6084/m9.figshare.21865677.
